| 2026-03-31 |
详情>>
内部人交易：
BAYERN JOSEPH等共交易4笔
|
| 2026-02-06 |
详情>>
业绩披露：
2026年三季报(累计)每股收益-0.39加拿大元,归母净利润-1.06亿加拿大元,同比去年增长71.96%
|
| 2026-02-06 |
财报披露：
美东时间 2026-02-06 盘前发布财报
|
| 2026-01-09 |
详情>>
股本变动：
变动后总股本37786.26万股
|
| 2025-11-07 |
详情>>
业绩披露：
2026年中报每股收益-0.19加拿大元,归母净利润-4316.6万加拿大元,同比去年增长83.10%
|
| 2025-08-08 |
详情>>
业绩披露：
2026年一季报每股收益-0.22加拿大元,归母净利润-4152.7万加拿大元,同比去年增长67.34%
|
| 2025-08-07 |
股东大会：
将于2025-09-26召开股东大会
会议内容 ▼▲
- 1.To receive and consider the audited consolidated financial statements of the Company as at March 31, 2025 and 2024 and for each of the years in the three-year period ended March 31, 2025, together with the auditors’ report thereon;
2.To elect to the board of directors of the Company (the “Board”) the five director nominees named in the attached proxy statement for the ensuing year;
3.To re-appoint PKF O’Connor Davies LLP as the Company’s auditor and independent registered public accounting firm for the fiscal year ending March 31, 2026 and to authorize the Board or any responsible committee thereof to fix their remuneration;
4.To consider and, if deemed advisable, to pass, with or without variation, a special resolution approving the amendment to the articles of the Company to provide that: (i) the authorized capital of the Company be altered by consolidating all of the issued and outstanding Shares and exchangeable shares on the basis of a ratio to be determined by the Board, in its sole discretion, within a range of one post-consolidation share for every five to fifteen outstanding pre-consolidation shares, at anytime prior to September 26, 2026, with the exact ratio to be set at a whole number within this range by the Board in its sole discretion and applicable for both the Shares and exchangeable shares; (ii) any fractional shares arising from the consolidation will be deemed to have been tendered by its registered owner to the Company for cancellation for no consideration;
5.To adopt, on an advisory (non-binding) basis, a resolution approving the compensation of the Company’s named executive officers, as described in the attached proxy statement;
6.To transact such other business as may properly come before the Meeting or any adjournment or postponement thereof.
|
| 2025-05-30 |
详情>>
业绩披露：
2023年年报每股收益-70.69加拿大元,归母净利润-32.78亿加拿大元,同比去年增长-957.32%
|
| 2025-05-30 |
详情>>
业绩披露：
2025年年报每股收益-5.56加拿大元,归母净利润-5.98亿加拿大元,同比去年增长9.00%
|
| 2025-02-07 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-4.09加拿大元,归母净利润-3.77亿加拿大元,同比去年增长33.21%
|
| 2024-11-08 |
详情>>
业绩披露：
2025年中报每股收益-3.08加拿大元,归母净利润-2.55亿加拿大元,同比去年增长26.63%
|
| 2024-11-08 |
详情>>
业绩披露：
2024年中报每股收益-5.49加拿大元,归母净利润-3.48亿加拿大元,同比去年增长85.36%
|
| 2024-08-09 |
详情>>
业绩披露：
2025年一季报每股收益-1.6加拿大元,归母净利润-1.27亿加拿大元,同比去年增长-233.51%
|
| 2024-08-01 |
股东大会：
将于2024-09-24召开股东大会
会议内容 ▼▲
- 1.To receive and consider the audited consolidated financial statements of the Company as at March 31, 2024 and 2023 and for each of the years in the three-year period ended March 31, 2024, together with the auditors’ report thereon;
2.To elect to the board of directors of the Company (the “Board”) the five director nominees named in the attached proxy statement for the ensuing year;
3.To re-appoint PKF O’Connor Davies LLP as the Company’s auditor and independent registered public accounting firm for the fiscal year ending March 31, 2025 and to authorize the Board or any responsible committee thereof to fix their remuneration;
4.To adopt, on an advisory (non-binding) basis, a resolution approving the compensation of the Company’s named executive officers, as described in the attached proxy statement;
5.To transact such other business as may properly come before the Meeting or any adjournment or postponement thereof.
|
| 2024-05-30 |
详情>>
业绩披露：
2024年年报每股收益-8.79加拿大元,归母净利润-6.57亿加拿大元,同比去年增长79.95%
|
| 2024-02-12 |
股东大会：
将于2024-04-12召开股东大会
会议内容 ▼▲
- 1.To consider, and if deemed advisable, pass a special resolution, as set forth in Appendix A to the accompanying proxy statement, to authorize and approve an amendment to the Company’s Articles of Incorporation, as amended (the “Articles”), in order to: (i) create and authorize the issuance of an unlimited number of a new class of non-voting and non-participating exchangeable shares (the “Exchangeable Shares”) and (ii) restate the rights of the Shares to provide for a conversion feature whereby each Share may at any time, at the option of the holder, be converted into one Exchangeable Share;
2.To transact such other business as may properly come before the Meeting or any adjournment or postponement thereof.
|
| 2024-02-09 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-8.08加拿大元,归母净利润-5.65亿加拿大元,同比去年增长78.59%
|
| 2023-12-20 |
复牌提示：
2023-12-19 19:50:00 停牌，复牌日期 2023-12-20 09:00:00
|
| 2023-12-20 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2023-08-09 |
股东大会：
将于2023-09-25召开股东大会
会议内容 ▼▲
- 1.To receive and consider the audited consolidated financial statements of the Company as at March 31, 2023 and 2022 and for each of the years in the three-year period ended March 31, 2023, together with the auditors’ report thereon;
2.To elect to the board of directors of the Company (the “Board”) the seven director nominees named in the attached proxy statement for the ensuing year;
3.To appoint PKF O’Connor Davies LLP, Chartered Professional Accountants, as the Company’s auditor and independent registered public accounting firm for the fiscal year ending March 31, 2024 and to authorize the Board to fix their remuneration;
4.To consider and, if deemed advisable, to pass, with or without variation, an ordinary resolution approving the adoption of the Company’s new equity incentive plan;
5.To consider and, if deemed advisable, to pass, with or without variation, a special resolution approving the amendment to the articles of the Company to provide that: (i) the authorized capital of the Company be altered by consolidating all of the issued and outstanding Shares on the basis of a ratio to be determined by the Board, in its sole discretion, within a range of 1 post-consolidation common share for every five to 15 outstanding pre-consolidation Share at anytime prior to September 25, 2024, with the exact ratio to be set at a whole number within this range by the Board in its sole discretion; and (ii) any fractional Shares arising from the consolidation of the Shares will be deemed to have been tendered by its registered owner to the Company for cancellation for no consideration;
6.To adopt, on an advisory (non-binding) basis, a resolution approving the compensation of the Company’s named executive officers, as described in the attached proxy statement;
7.To consider and, if deemed advisable, to pass, with or without variation, an ordinary resolution approving the issuance of Shares in excess of 19.99% and 25%, as applicable, of the issued and outstanding Shares of the Company in accordance with the applicable rules and regulations of the Nasdaq Stock Market LLC and the Toronto Stock Exchange in connection with privately negotiated redemption agreements dated July 13, 2023 between the Company and certain arm’s-length holders of 4.25% unsecured senior notes of the Company due 2023, as described in the attached proxy statement;
8.To transact such other business as may properly come before the Meeting or any adjournment or postponement thereof.
|
| 2022-07-29 |
股东大会：
将于2022-09-15召开股东大会
会议内容 ▼▲
- 1.To receive and consider the audited consolidated financial statements of the Company as at March 31, 2022 and 2021 and for each of the years in the three-year period ended March 31, 2022, together with the auditors’ report thereon;
2.To elect to the board of directors of the Company (the “Board””) the seven director nominees named in the attached proxy statement for the ensuing year;
3.To re-appoint KPMG LLP, Chartered Professional Accountants, as the Company’s auditor and independent registered public accounting firm for the fiscal year 2023 and to authorize the Board to fix their remuneration;
4.To consider and, if deemed advisable, pass an ordinary resolution approving the renewal of the Company’s employee stock purchase plan, as described in more detail in the accompanying proxy statement;
5.To adopt, on an advisory (non-binding) basis, a resolution approving the compensation of the Company’s named executive officers, as described in the attached proxy statement;
6.To transact such other business as may properly come before the Meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-07-29 |
股东大会：
将于2021-09-14召开股东大会
会议内容 ▼▲
- 1.to receive and consider the audited consolidated financial statements of the Company as at March 31, 2021 and 2020 and for each of the years in the three-year period ended March 31, 2021, together with the auditors’ report thereon;
2.to elect to the board of directors of the Company (the “Board” or “Board of Directors”) the seven director nominees named in the attached proxy statement for the ensuing year;
3.to re-appoint KPMG LLP, Chartered Professional Accountants, as the Company’s auditor and independent registered public accounting firm for the fiscal year 2021 and to authorize the Board to fix their remuneration;
4.to consider and, if deemed appropriate, approve an ordinary resolution confirming and ratifying certain amendments to the Company’s By-laws (the “By-laws”), including an increase in the quorum requirements for meetings of Shareholders and other amendments of a housekeeping nature, that were previously approved by the Board and as set forth in Appendix A to the accompanying proxy statement and as described in more detail in the accompanying proxy statement;
5.to adopt, on an advisory (non-binding) basis, a resolution approving the compensation of the Company’s named executive officers, as described in the attached proxy statement;
6.to transact such other business as may properly come before the Meeting or any adjournment or postponement thereof.
|
| 2020-08-07 |
股东大会：
将于2020-09-21召开股东大会
会议内容 ▼▲
- 1.to receive and consider the audited consolidated financial statements of the Company as at March 31, 2020 and 2019 and for each of the years in the three-year period ended March 31, 2020, together with the auditors’ report thereon;
2.to elect to the board of directors of the Company (the “Board” or “Board of Directors”) the seven director nominees named in the attached Proxy Statement for the ensuing year;
3.to re-appoint KPMG LLP, Chartered Professional Accountants, as the Company’s independent registered public accounting firm for the fiscal year 2021 and to authorize the Board to fix their remuneration;
4.to approve certain amendments to the Company’s Amended and Restated Omnibus Incentive Plan (the “Omnibus Incentive Plan”) and all unallocated awards issuable under the Omnibus Incentive Plan, as described in the attached Proxy Statement;
5.to approve certain amendments to the Company’s 2017 Employee Stock Purchase Plan, as described in the attached Proxy Statement;
6.to adopt, on an advisory (non-binding) basis, a resolution approving the compensation of the Company’s named executive officers, as described in the attached Proxy Statement;
7.to adopt, on an advisory (non-binding) basis, a resolution on the frequency of future “say-on-pay” votes, as described in the attached Proxy Statement;
8.to transact such other business as may properly come before the Meeting or any adjournment or postponement thereof.
|
| 2019-08-16 |
股东大会：
将于2019-09-17召开股东大会
会议内容 ▼▲
- 1.to receive and consider the audited consolidated financial statements of the Company for the financial year ended March 31, 2019 and 2018, together with the auditors’ report thereon;
2.to elect the directors of the Company for the ensuing year;
3.to re-appoint KPMG LLP, Chartered Professional Accountants as the auditors of the Company for the ensuing year and to authorize the board of directors of the Company (the “Board”) to fix their remuneration;
4.to transact such other business as may properly be brought before the Meeting or any adjournment or postponement thereof.
|
| 2019-05-23 |
股东大会：
将于2019-06-19召开股东大会
会议内容 ▼▲
- 1.to consider and, if thought advisable, to pass, with or without variation, an ordinary resolution (the “Canopy Shareholder Resolution”), the full text of which is included as Appendix A attached to the accompanying management information circular of Canopy dated May 17, 2019 (the “Circular”) authorizing:
(a)the issuance by Canopy of up to 109,515,459 common shares in the capital of Canopy (“Canopy Shares”) as consideration in connection with a plan of arrangement under the Business Corporations Act (British Columbia) (the “Arrangement”) involving Canopy and Acreage Holdings, Inc. (“Acreage”), pursuant to which Canopy will obtain an option to acquire all of the issued and outstanding shares of Acreage, as more fully described in the accompanying Circular (as the Arrangement may be, or may have been, modified or amended in accordance with its terms);
(b)the issuance by Canopy of up to 61,711,961 Canopy Shares to CBG Holdings LLC (“CBG”) and/or Greenstar Canada Investment Limited Partnership (“GCILP” and together with CBG, the “CBG Group”) as is necessary to satisfy the top-up right held by the CBG Group pursuant to the terms of the second amended and restated investor rights agreement dated April 18, 2019 between Canopy and the CBG Group, as more fully-described in the accompanying Circular;
(c)the amendments (the “CBG Amendments”) to the terms of the 88,472,861 issued and outstanding Tranche A warrants and the 51,272,592 issued and outstanding Tranche B warrants of Canopy held by CBG pursuant to the terms of the consent agreement dated April 18, 2019 between CBG and Canopy, as more fully described in the accompanying Circular;
2.to transact such further and other business as may properly be brought before the Canopy Meeting or any adjournment or postponement thereof.
|
| 2018-10-24 |
股东大会：
将于2018-09-26召开股东大会
会议内容 ▼▲
- 1.receive the audited financial statements of the Corporation for the financial year ended March 31, 2018, together with the report of the auditors thereon;
2.elect directors (subject to approval of the Transaction (as defined in the accompanying management information circular (“Circular”));
3.appoint our auditor and authorized the directors of the Corporation to fix their remuneration;
4.consider and, if thought advisable, approve an ordinary resolution, the full text of which is set forth in Schedule A to the accompanying Circular, authorizing the Corporation to issue on a private placement basis 104,500,000 common shares in the capital of the Corporation (the “Common Shares”) and 139,745,453 warrants to purchase Common Shares to CBG Holdings LLC (or its affiliates or permitted assignees); the removal of Murray Goldman and Chris Schnarr as directors of the Corporation; the election of William Newlands, David Klein and Judy Schmeling as directors of the Corporation; and certain other matters relating to the Transaction;
5.transact any other business which may properly come before the meeting.
|